SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pursue business opportunities.
- As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pursue business opportunities.
- CBM is a U.S. cell and gene therapy CDMO in which SK pharmteco recently acquired a controlling interest.
- At CPHI, SK pharmteco aims to leverage various networking events to showcase its key strengths.
- For more on SK pharmteco, visit skpharmteco.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/sk-pharmteco-to-showcase-its-ex...